Details of the Drug-Related molecule(s) Interaction Atlas

General Information of Drug (ID: DM9GC4R)

Drug Name

VGX-100 Drug Info

Indication

Disease Entry	ICD 11	Status	REF
Solid tumour/cancer	2A00-2F9Z	Phase 1	[1]

Cross-matching ID

Molecule-Related Drug Atlas

Molecule Type:

DTT

Drug Status:

Clinical Trial Drug(s)

Download the Complete Related Drug List

Drug(s) Targeting Vascular endothelial growth factor C (VEGFC)

Drug Name	Drug ID	Indication	ICD 11	Highest Status	REF
OPT-302	DMS4XFI	Diabetic macular edema	9B71.02	Phase 2	[3]
------------------------------------------------------------------------------------

Molecular Interaction Atlas of This Drug

Molecular Interaction Atlas

Download the Complete Interaction Atlas for Visualization in Cytoscape

Drug Therapeutic Target (DTT)

DTT Name	DTT ID	UniProt ID	MOA	REF
Vascular endothelial growth factor C (VEGFC)	TT0QUFV	VEGFC_HUMAN	Modulator	[2]

------------------------------------------------------------------------------------

References

1	ClinicalTrials.gov (NCT01514123) Study of VGX-100 Administered Alone and Co-administered With Bevacizumab in Adult Subjects With Advanced Solid Tumors. U.S. National Institutes of Health.
2	National Cancer Institute Drug Dictionary (drug id 724066).
3	Clinical pipeline report, company report or official report of Opthea.